Predictive value and clinical treatment guidance of uterine artery blood flow parameters for recurrent pregnancy loss.

OA: closed
📄 Open PDF View on PubMed View at publisher
AI-generated summary by qwen3.7-flash, 2026-09-16

This study found that elevated uterine artery S/D and PI ratios predict adverse pregnancy outcomes in recurrent pregnancy loss, with combined aspirin, nifedipine, and sildenafil treatment significantly improving hemodynamics and reducing miscarriage risk.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveThis study investigates the relationship between uterine artery blood flow parameters and the number of miscarriages, etiology, treatment protocol, and pregnancy outcomes in patients with recurrent pregnancy loss (RPL).MethodsA retrospective observational cohort analysis was conducted on data from patients with RPL and women with a normal pregnancy who visited Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine and the International Peace Maternity and Child Health Hospital between October 2017 and December 2024. The study observed various parameters of uterine artery blood flow, comparing differences in the number of miscarriages, etiology, treatment protocol, and pregnancy outcomes. Receiver operating characteristic (ROC) curves were used to evaluate the predictive value of blood flow parameters on pregnancy outcomes.ResultsThe study included 652 patients with RPL and 432 pregnant women with normal pregnancy. First, with increasing gestational age, the uterine artery systolic/end-diastolic velocity (S/D), pulsatility index (PI), and blood flow resistance index (RI) showed a downward trend in normal pregnancy. Second, as the number of spontaneous miscarriages increased, the uterine artery blood flow S/D ratio and PI value gradually increased, while the peak systolic velocity (PSV) and RI values showed no significant correlation with the number of miscarriages. Third, in patients with RPL caused by immunological factors, the uterine artery S/D ratio, PI, and RI values were significantly elevated. In contrast, in RPL patients caused by endocrine factors, although the S/D ratio, PI, and RI values also tended to increase, the magnitude of increase was much less compared to RPL caused by immunological factors. In patients with unexplained RPL, the uterine artery S/D ratio, PI, and RI values were also significantly elevated. In RPL patients due to chromosomal factors, the uterine artery blood flow parameters showed no significant difference compared to the normal pregnancy. Fourth, after treatment, the S/D ratio and RI and PI values significantly decreased (P < 0.05), and PSV increased (P < 0.05), suggesting a significant negative correlation between pre-treatment uterine artery S/D ratio, PI value, and pregnancy outcomes (P < 0.05). Fifth, combined medication (aspirin + nifedipine + sildenafil) was most effective, significantly reducing S/D, PI, and RI (P < 0.05) and markedly improving pregnancy outcomes (P < 0.05). Finally, ROC analysis showed that S/D (area under the curve [AUC] = 0.8385) and PI (AUC = 0.8130) had a high predictive value for adverse pregnancy outcomes, with optimal thresholds of 12.85 and 4.265, respectively.ConclusionUterine artery blood flow parameters (particularly S/D ratio and PI) can serve as predictive indicators of pregnancy outcomes in patients with RPL. Combined pharmacological treatment can significantly improve hemodynamics and reduce the risk of miscarriage.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

SciLite annotations

chemicals 12
clopidogrel nifedipine sildenafil glucose clopidogrel nifedipine sildenafil diethylcarbamazine citrate creatinine oxygen thromboxanes a heparin
organisms 1
human

Source provenance

europepmc
last seen: 2026-09-13T09:25:22.628771+00:00
scilite
last seen: 2026-09-13T09:58:29.948030+00:00
unpaywall
last seen: 2026-09-16T06:28:21.314993+00:00